HemostOD receives a FIT Tech Growth loan

HemostOD received the support of the "Fondation pour l'Innovation Technologique" (FIT) in the form of a CHF 500'000 loan: the FIT Tech Growth. The FIT Tech programme supports Swiss startups in their development and to accelerate their commercialization.

This significant funding will enable HemostOD to accelerate the development of our universal platelet manufacturing platform and advance our clinical programs. The support from FIT represents a major milestone in our journey to revolutionize platelet therapy and address the global shortage of platelet transfusions.

About FIT Tech Growth: The FIT Tech Growth program is designed to support innovative Swiss companies in their growth phase, helping them scale their operations and bring their breakthrough technologies to market.

For more information: FIT Foundation News